Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Andrés Pascual, Thierry Calandra, S. Bolay et al. · Clinical Infectious Diseases · 2007 · 889 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic/Pharmacodynamic Profile of Voriconazole

Ursula Theuretzbacher, Franziska Ihle, Hartmut Derendorf · Clinical Pharmacokinetics · 2006 · 475 citations

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration

Thomas J. Walsh, Mats O. Karlsson, Timothy Driscoll et al. · Antimicrobial Agents and Chemotherapy · 2004 · 335 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six <i>Aspergillus</i> spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Ana Espinel-Ingroff, Daniel J. Diekema, Annette W. Fothergill et al. · Journal of Clinical Microbiology · 2010 · 236 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model

David R. Andes, Karen Marchillo, T. Stamstad et al. · Antimicrobial Agents and Chemotherapy · 2003 · 229 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17